Austin-Asomeji Iyingiala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Austin-Asomeji Iyingiala has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Morufu Olalekan Raimi
Federal University, Otuoke, Nigeria
5 shared publications Odangowei Inetiminebi Ogidi
Bayelsa Medical University
4 shared publications- Esther Omone Akhigbe
Federal University Otuoke
3 shared publications - Matthew Chidozie Ogwu
Appalachian State University, USA
2 shared publications - Muhammad Akram
Department of eastern medicine, government college university Faisalabad
2 shared publications Saoban Sunkanmi Salimon
School of Biological and Medical Physics, Moscow Institute of Physics and Technology
2 shared publications
Latest Publications
- 10 July 2024
- Published by Springer Nature
- p. 3-35
Historical Perspectives and Overview of the Value of Herbal Medicine
- 10 July 2024
- Published by Springer Nature
- p. 3-35
Historical Perspectives and Overview of the Value of Herbal Medicine
- Open Access
- 1 July 2024
- Published by MDPI AG in Preprints.org
Evaluating the Anti-cancer Potential of Ganoderma lucidum: A Critical Analysis of Clinical Evidence and Methodological Advances
Rationale: A wide range of bioactive phytoconstituents from edible fungi, especially therapeutic mushrooms, have the potential to improve health, especially in the case of chronic illnesses. Known for its anti-cancer qualities, ganoderma lucidum has been the focus of multiple clinical studies. Existing systematic reviews imply that more clinical research and methodological refinement are necessary to support its usage as a primary cancer treatment.Objective: The objective of this research is to evaluate the anti-cancer potential of the bioactive phytoconstituents found in mushrooms, specifically Ganoderma lucidum, in a thorough manner. The aim is to conduct a critical assessment of the extant literature, pinpoint any deficiencies, and offer valuable perspectives on the methodological excellence and research requirements in this domain.Method(s): A thorough analysis of published clinical trials was carried out, with a focus on studies that examined the effectiveness of Ganoderma lucidum and other products derived from mushrooms in treating cancer. The study's design, stated results, and methodological rigor were all carefully examined to evaluate the validity and reliability of the conclusions.Results: Despite Ganoderma lucidum's potential against cancer, the evaluation finds insufficient data to support its widespread usage as a primary cancer treatment. Products made from mushrooms, which are frequently sold as dietary supplements, have anti-cancer claims. But since pre-approval is not required under US regulatory framework in order to market food supplements, these statements raise questions regarding their scientific validity.Conclusions/Recommendations: The study's result emphasizes the necessity of more methodological advancement in clinical studies examining Ganoderma lucidum's potential as an anti-cancer agent. It also highlights the significance of thorough scientific validation for goods made from mushrooms that make health claims. To establish accurate claims regarding their anti-cancer effects, recommendations include developing technological methods for the purification of bioactive substances and undertaking thorough studies of mushroom products from different geographical regions. The goal of this thorough analysis is to direct future investigations and support the ethical promotion and use of products derived from mushrooms for medical purposes.
- 1 July 2024
- Published by MDPI AG in Preprints.org
Open AccessEvaluating the Anti-cancer Potential of Ganoderma lucidum: A Critical Analysis of Clinical Evidence and Methodological Advances
Rationale: A wide range of bioactive phytoconstituents from edible fungi, especially therapeutic mushrooms, have the potential to improve health, especially in the case of chronic illnesses. Known for its anti-cancer qualities, ganoderma lucidum has been the focus of multiple clinical studies. Existing systematic reviews imply that more clinical research and methodological refinement are necessary to support its usage as a primary cancer treatment.Objective: The objective of this research is to evaluate the anti-cancer potential of the bioactive phytoconstituents found in mushrooms, specifically Ganoderma lucidum, in a thorough manner. The aim is to conduct a critical assessment of the extant literature, pinpoint any deficiencies, and offer valuable perspectives on the methodological excellence and research requirements in this domain.Method(s): A thorough analysis of published clinical trials was carried out, with a focus on studies that examined the effectiveness of Ganoderma lucidum and other products derived from mushrooms in treating cancer. The study's design, stated results, and methodological rigor were all carefully examined to evaluate the validity and reliability of the conclusions.Results: Despite Ganoderma lucidum's potential against cancer, the evaluation finds insufficient data to support its widespread usage as a primary cancer treatment. Products made from mushrooms, which are frequently sold as dietary supplements, have anti-cancer claims. But since pre-approval is not required under US regulatory framework in order to market food supplements, these statements raise questions regarding their scientific validity.Conclusions/Recommendations: The study's result emphasizes the necessity of more methodological advancement in clinical studies examining Ganoderma lucidum's potential as an anti-cancer agent. It also highlights the significance of thorough scientific validation for goods made from mushrooms that make health claims. To establish accurate claims regarding their anti-cancer effects, recommendations include developing technological methods for the purification of bioactive substances and undertaking thorough studies of mushroom products from different geographical regions. The goal of this thorough analysis is to direct future investigations and support the ethical promotion and use of products derived from mushrooms for medical purposes.
- 29 October 2023
- Published by Springer Nature
- p. 1-33
Historical Perspectives and Overview of the Value of Herbal Medicine
- 29 October 2023
- Published by Springer Nature
- p. 1-33
Historical Perspectives and Overview of the Value of Herbal Medicine
- Open Access
- 6 March 2023
- Published by MDPI AG in Preprints.org
A Concise Study on Essential Parameters for the Sustainability of Lagoon Waters in Terms of Scientific Literature
Lagoons are becoming sporadically utilised albeit they are equipped with high potential for the outsourcing of environmental and industrial benefits. It leads to the endangered pollution of lagoon water aquatic system. The prime reason is the lack of knowledge among stakeholders and researchers regarding the influential parameters in establishing the lagoon water quality. The optimal quality for lagoon water is critical for the longevity of aquatic ecosystem. This study focuses on using bibliographic references to find the most influential factors determining the water quality in lagoons for deriving a comprehensive long-term water quality monitoring plan to ensure the sustainability of the lagoon water ecosystem. The lagoon water quality was classified in this study into biological, physical, and chemical parameters and studied for their importance upon enhancing the water quality. Experiments were conducted on selected parameters using the water samples from the selected Sri Lankan lagoons with available facilities to observe the water quality. The overall findings on physiochemical and biological characteristics using the experiments temperature, turbidity, pH, salinity, DO, BOD, COD, phosphates, nitrates, ammonia content and faecal coliforms in water specimens suggest that the selected Sri Lankan lagoons are heavily polluted due to their distinctive variations from the allowable threshold limits specified in the literature sources. To increase such increased risks associated with lagoon water systems, a long-term monitoring strategy is recommended to be incorporated at lagoon waters in order to assure their sustainability.
- 6 March 2023
- Published by MDPI AG in Preprints.org
Open AccessA Concise Study on Essential Parameters for the Sustainability of Lagoon Waters in Terms of Scientific Literature
Lagoons are becoming sporadically utilised albeit they are equipped with high potential for the outsourcing of environmental and industrial benefits. It leads to the endangered pollution of lagoon water aquatic system. The prime reason is the lack of knowledge among stakeholders and researchers regarding the influential parameters in establishing the lagoon water quality. The optimal quality for lagoon water is critical for the longevity of aquatic ecosystem. This study focuses on using bibliographic references to find the most influential factors determining the water quality in lagoons for deriving a comprehensive long-term water quality monitoring plan to ensure the sustainability of the lagoon water ecosystem. The lagoon water quality was classified in this study into biological, physical, and chemical parameters and studied for their importance upon enhancing the water quality. Experiments were conducted on selected parameters using the water samples from the selected Sri Lankan lagoons with available facilities to observe the water quality. The overall findings on physiochemical and biological characteristics using the experiments temperature, turbidity, pH, salinity, DO, BOD, COD, phosphates, nitrates, ammonia content and faecal coliforms in water specimens suggest that the selected Sri Lankan lagoons are heavily polluted due to their distinctive variations from the allowable threshold limits specified in the literature sources. To increase such increased risks associated with lagoon water systems, a long-term monitoring strategy is recommended to be incorporated at lagoon waters in order to assure their sustainability.